DATED 5 APRIL 2012 Amsterdam Molecular Therapeutics (AMT) B.V. and Amsterdam Molecular Therapeutics (AMT) IP B.V. as the Transferees and Amsterdam Molecular Therapeutics (AMT) Holding N.V. as the Transferor